+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Evaluation of gene therapy as a treatment for equine traumatic arthritis and osteoarthritis

Evaluation of gene therapy as a treatment for equine traumatic arthritis and osteoarthritis

Clinical Orthopaedics and Related Research 2000(379 Suppl): S273-S287

Joint disease in horses and in humans is a significant social and economic problem and continued research and improvements in therapeutics are needed. Because horses have naturally occurring osteoarthritis that is similar to that of humans, the horse was chosen as a species to investigate gene transfer as a potential therapeutic modality for the treatment of osteoarthritis. Using an established model of equine osteoarthritis, the therapeutic effects resulting from overexpression the equine interleukin-1 receptor antagonist gene sequence through adenoviral mediated gene transfer was investigated. The results of the current study showed intraarticular expression of interleukin-1 receptor antagonist to have favorable effects such as an approximately 28 day upregulation of interleukin-1 receptor antagonist protein expression, significant improvement in clinical parameters of pain and disease activity, and beneficial effects in histologic parameters measured from synovial membrane and articular cartilage when compared with nontransduced joints. Based on the significant improvements seen in this work gene transfer of interleukin-1 receptor antagonist is a practical treatment modality for the equine patient and also offers future promise for human patients.

(PDF emailed within 0-6 h: $19.90)

Accession: 046010044

Download citation: RISBibTeXText

PMID: 11039781

DOI: 10.1097/00003086-200010001-00037

Related references

Gene Therapy for Osteoarthritis: Pharmacokinetics of Intra-Articular Self-Complementary Adeno-Associated Virus Interleukin-1 Receptor Antagonist Delivery in an Equine Model. Human Gene Therapy. Clinical Development 29(2): 90-100, 2018

Treatment of experimental equine osteoarthritis by in vivo delivery of the equine interleukin-1 receptor antagonist gene. Gene Therapy 9(1): 12-20, January, 2002

Treatment of traumatic arthritis using gene therapy. Proceedings of the annual convention6(46): 36-38, 2000

Evaluation of topical diclofenac liposomal cream for treatment of equine osteoarthritis using an equine experimental model. 2007

Recent advances in the treatment of traumatic arthritis in the equine athlete. Proceedings of the North American Veterinary Conference5(15): 120-122, 2001

Self-Complementary Adeno-Associated Virus-Mediated Interleukin-1 Receptor Antagonist Gene Delivery for the Treatment of Osteoarthritis: Test of Efficacy in an Equine Model. Human Gene Therapy. Clinical Development 29(2): 101-112, 2018

Treatment of equine joint diseases. Part 2: Surgical and physical treatment of equine osteoarthritis. UK Vet: Companion Animal 12(8): 10-15, 2007

Combinatorial Prg4 and Il-1ra Gene Therapy Protects Against Hyperalgesia and Cartilage Degeneration in Post-Traumatic Osteoarthritis. Human Gene Therapy 2018, 2018

Evaluation of intra-articular polysulfated glycosaminoglycan and sodium hyaluronan for treatment of osteoarthritis using an equine experimental model. Proceedings Of The 54th Annual Convention Of The American Association Of Equine Practitioners, San Diego, California, Usa, 6-10: 0-251, 2008

Galectins-1 and-3 Increase in Equine Post-traumatic Osteoarthritis. Frontiers in Veterinary Science 5: 288, 2018

Treatment of equine joint diseases. Part 1: Pharmacological management of equine osteoarthritis (OA). UK Vet: Companion Animal 12(4): 9-15, 2007

Effectiveness of Distraction Therapy Assisted by Arthroscope in Treatment of Ankle Traumatic Osteoarthritis. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 30(2): 161-164, 2016

Stem cells may be coming therapy for bone and joint injuries. Post-traumatic arthritis (PTA), a form of osteoarthritis, may no longer be the norm following joint injury. Dukemedicine Healthnews 19(12): 6-6, 2014

An MRI Evaluation of Patients Who Underwent Treatment with a Cell-Mediated Gene Therapy for Degenerative Knee Arthritis: A Phase IIa Clinical Trial. Journal of Knee Surgery 30(7): 694-703, 2016

Nonsteroidal therapy of rheumatoid arthritis and osteoarthritis: how physicians manage treatment failures. Journal of Rheumatology 25(11): 2088-2093, 1998